Key Takeaways STE is set to report Q3 on Feb. 4, with revenues seen at $1.48B and EPS at$2.53, up year over year. STERIS expects Healthcare momentum, with capital equipment orders robust and segment revenues up 8.1%. STE's AST and Life Sciences are seen growing about 8%, aided by organic growth and MedTech demand. STERIS plc (STE) is scheduled to release third-quarter fiscal 2026 results on Feb. 4, after market close.In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.4 ...